This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox (CLX) Earnings and Sales Surpass Estimates in Q1
by Zacks Equity Research
Clorox (CLX) posts solid first-quarter fiscal 2019 numbers. Further, management trimmed its earnings view for the fiscal year, while reaffirmed sales outlook.
Archer Daniels Midland (ADM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
ADM (ADM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors That Hold Key to Hain Celestial (HAIN) Q1 Earnings
by Zacks Equity Research
Hain Celestial's (HAIN) Project Terra program is likely to improve productivity and facilitate cost reductions. However, any deleverage in freight and commodity expenses may weigh on margins.
What's in the Offing for Avon (AVP) This Earnings Season?
by Zacks Equity Research
Avon (AVP) is witnessing sales and earnings decline for the last few years on account of slowed Representatives growth. However, the company's Transformation plan remains encouraging.
Can Clorox (CLX) Retain its Earnings Beat Streak in Q1?
by Zacks Equity Research
Clorox (CLX) gains from its 2020 Strategy, Go Lean Strategy, enhancement of e-commerce business and disciplined capital allocation, which are likely to drive first-quarter fiscal 2019 results.
Factors Likely to Influence Molson Coors' (TAP) Q3 Earnings
by Zacks Equity Research
Molson Coors (TAP) has a dismal top and bottom line trend. Also, it continues to battle input cost inflation. However, its restructuring plans to reduce costs and boost profitability are impressive.
Boston Beer (SAM) Beats on Q3 Earnings & Sales, Ups 2018 View
by Zacks Equity Research
Boston Beer (SAM) tops earnings and sales estimates for third-quarter 2018, backed by solid depletion growth and robust shipment volume.
Colgate's (CL) Q3 Earnings In Line, Sales Miss Estimates
by Zacks Equity Research
Colgate (CL) posts in-line earnings in third-quarter 2018 with a top line miss. Also, it expects a challenging backdrop moving ahead.
Archer Daniels Midland (ADM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Archer Daniels Midland (ADM) closed at $47.90, marking a +0.31% move from the previous day.
AB InBev (BUD) Lags on Q3 Earnings & Sales, Retains View
by Zacks Equity Research
AB InBev (BUD) posts earnings and sales miss in third-quarter 2018. Higher commodity prices offset gains from revenue management initiatives, strength in premium brands and cost savings.
B&G Foods (BGS) Q3 Earnings: Factors Shaping the Outcome
by Zacks Equity Research
B&G Foods' (BGS) high freight costs remain a threat to margins in Q3. However, the company's top line has been gaining from strength in its Green Giant business, which is a positive.
3 Blue-Chip Stocks to Buy Amid Global Conflicts
by Zacks Equity Research
These blue-chip stocks should survive the rising tensions and generate profits better than others.
5 Consumer Staples Stocks to Buy in a Volatile Market
by Nalak Das
Negative sentiments have dented investor confidence to such an extent that strong third quarter earnings results have failed to instill optimism.
Will Higher Expenses Weigh on FEMSA's (FMX) Q3 Earnings?
by Zacks Equity Research
FEMSA's (FMX) dismal surprise history and soft margins can be attributed to higher raw material costs. However, its growth initiatives are encouraging.
Factors to Know Before Service Corporation (SCI) Q3 Earnings
by Zacks Equity Research
Service Corporation (SCI) is likely to gain from its strategic growth efforts, which are primarily aimed at increasing revenues and utilizing scale. However, soft cemetery revenues are a worry.
Will Soft Beer Sales Hurt AB InBev's (BUD) Earnings in Q3?
by Zacks Equity Research
AB InBev (BUD) suffers due to industry-wide decline in beer sales as consumers shift to healthier drinks. However, the company's robust outlook inspires optimism.
Will Higher Costs Mar Boston Beer's (SAM) Earnings in Q3?
by Zacks Equity Research
Boston Beer's (SAM) three-point growth plan focused on cost-saving actions, long-term innovation, and revival of Samuel Adams and Angry Orchard brands bodes well despite high costs.
Procter & Gamble (PG) Catches Eye: Stock Jumps 8.8%
by Zacks Equity Research
Procter & Gamble (PG) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
New Strong Buy Stocks for October 19th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Archer Daniels Midland (ADM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Archer Daniels Midland (ADM) closed the most recent trading day at $49.21, moving +0.37% from the previous trading session.
Is Archer Daniels Midland (ADM) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (ADM) Outperforming Other Consumer Staples Stocks This Year?
New Strong Buy Stocks for October 16th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
4 Reasons Why Boston Beer (SAM) Must Be in Your Portfolio
by Zacks Equity Research
Boston Beer (SAM) shows resilience, driven by progress on three-point growth plan, focused on cost-saving initiatives, long-term innovation, and revival of Samuel Adams and Angry Orchard brands.
The Zacks Analyst Blog Highlights: Advance Auto Parts, Atlas Air Worldwide Holdings, ABIOMED, Archer-Daniels-Midland and Amerisafe
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Advance Auto Parts, Atlas Air Worldwide Holdings, ABIOMED, Archer-Daniels-Midland and Amerisafe
Top Ranked Income Stocks to Buy for October 15th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 15th: